May 2013
New Clinical Trial

The Cardiac Research Program offers a new five-year clinical trial for treating hypercholesterolemia.

FOURIER (Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk) involves a PCSK9 inhibitor vs. placebo subcutaneously selfinjected biweekly, plus maximally tolerated Atorvastatin.

Qualified participants are individuals age 40-85 who experienced a myocardial infarction (MI) or stroke within the last five years with either:

  • One major risk factor (Type 2 diabetes, over age 65, another MI or stroke in the last six months)
  • Two minor risk factors (elevated lipid levels, hypertension, elevated blood sugar)

For more information, contact Valerie Assalone, RN, CCRP (ext. 3193) or Tina Cullen, RN, CCRC (ext. 4849).

dating for married what to do when husband cheats unfaithful spouse